STAT3 and Familial prostate cancer: In both LNCaP and PC3 cell variants higher levels of TLR9 expression and activation (by CpG ODN stimulation) correlated with increased mRNA and protein levels of IL-6, an important STAT3 activator and a contributor to prostate cancer progression [19].